Effects of LDL-lowering plus HDL-raising on coronary atherosclerosis progression and clinical events in CAD patients with metabolic syndrome: A meta-analysis of the familial atherosclerosis treatment study (FATS), the HDL atherosclerosis treatment study (HATS), and the armed forces regression study (AFREGS)
Publication
, Conference
Baer, J; Zhao, X-Q; Krasuski, RA; Whitney, EJ; Neradilek, B; Chait, A; Marcovina, S; Albers, JJ; Brown, BG
Published in: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
June 1, 2008
Duke Scholars
Published In
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
ISSN
1079-5642
Publication Date
June 1, 2008
Volume
28
Issue
6
Start / End Page
E59 / E59
Location
Atlanta, GA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
9th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
Related Subject Headings
- Cardiovascular System & Hematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Baer, J., Zhao, X.-Q., Krasuski, R. A., Whitney, E. J., Neradilek, B., Chait, A., … Brown, B. G. (2008). Effects of LDL-lowering plus HDL-raising on coronary atherosclerosis progression and clinical events in CAD patients with metabolic syndrome: A meta-analysis of the familial atherosclerosis treatment study (FATS), the HDL atherosclerosis treatment study (HATS), and the armed forces regression study (AFREGS). In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (Vol. 28, pp. E59–E59). Atlanta, GA: LIPPINCOTT WILLIAMS & WILKINS.
Baer, Jefferson, Xue-Qiao Zhao, Richard A. Krasuski, Edwin J. Whitney, Blazej Neradilek, Alan Chait, Santica Marcovina, John J. Albers, and B. G. Brown. “Effects of LDL-lowering plus HDL-raising on coronary atherosclerosis progression and clinical events in CAD patients with metabolic syndrome: A meta-analysis of the familial atherosclerosis treatment study (FATS), the HDL atherosclerosis treatment study (HATS), and the armed forces regression study (AFREGS).” In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 28:E59–E59. LIPPINCOTT WILLIAMS & WILKINS, 2008.
Baer J, Zhao X-Q, Krasuski RA, Whitney EJ, Neradilek B, Chait A, et al. Effects of LDL-lowering plus HDL-raising on coronary atherosclerosis progression and clinical events in CAD patients with metabolic syndrome: A meta-analysis of the familial atherosclerosis treatment study (FATS), the HDL atherosclerosis treatment study (HATS), and the armed forces regression study (AFREGS). In: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2008. p. E59–E59.
Baer, Jefferson, et al. “Effects of LDL-lowering plus HDL-raising on coronary atherosclerosis progression and clinical events in CAD patients with metabolic syndrome: A meta-analysis of the familial atherosclerosis treatment study (FATS), the HDL atherosclerosis treatment study (HATS), and the armed forces regression study (AFREGS).” ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, vol. 28, no. 6, LIPPINCOTT WILLIAMS & WILKINS, 2008, pp. E59–E59.
Baer J, Zhao X-Q, Krasuski RA, Whitney EJ, Neradilek B, Chait A, Marcovina S, Albers JJ, Brown BG. Effects of LDL-lowering plus HDL-raising on coronary atherosclerosis progression and clinical events in CAD patients with metabolic syndrome: A meta-analysis of the familial atherosclerosis treatment study (FATS), the HDL atherosclerosis treatment study (HATS), and the armed forces regression study (AFREGS). ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2008. p. E59–E59.
Published In
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
ISSN
1079-5642
Publication Date
June 1, 2008
Volume
28
Issue
6
Start / End Page
E59 / E59
Location
Atlanta, GA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
9th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
Related Subject Headings
- Cardiovascular System & Hematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology